JUL 28, 2016 09:10 AM PDT

Molecule Made in the Human Body can Kill Antibiotic Resistant Bugs

WRITTEN BY: Carmen Leitch
Researchers studying the bacterium Staphylococcus lugdunensis in its natural environment have stumbled onto an amazing discovery. The microbe, which resides in the human nose, produces a molecule called lugdunin. That chemical is a natural antibiotic, and it kills the pathogenic and methicillin-resistant Staphylococcus aureus (otherwise known as MRSA) in rodents.
The human nose holds surprises. / Credit: WIN-Initiative/Getty
While the Staphylococcus aureus bacterium lives in the noses of many people and is normally harmless, the MRSA strain of S. aureus is resistant to many antibiotics and is found in the noses of 2 in 100 people. When the bacterium escapes from the nasal passages into the bloodstream, a relatively rare event, it causes infection. MRSA is a deadly bacterium though, killing around 11,000 people every year in the U.S. alone.

Antibiotics must selectively target invasive pathogens while leaving harmless host cells intact. Antibiotics are typically small molecules that work by attacking bacterial enzymes, critical proteins that bacteria need to survive.

Reporting in Nature, a molecule that is unlike typical antibiotics is described as a potential new fighter in the battle against MRSA. That molecule, lugdunin, is different from antibiotics normally used in that it’s a lot bigger. It isn’t completely understood how it works, either, though it involves the cell membrane. That unique mode of efficacy may be why bacterial strains of S. aureus were not able to become resistant to lugdunin in a 30-day trial done in tubes in the lab. “We never found spontaneous mutants,” says Andreas Peschel of the University of Tübingen, Germany, an author of the study.

In the work, in a group of 187 hospital patients, people who naturally carried S. lugdunensis in their noses were found to be six times less likely to carry S. aureus than people whose noses lacked S. lugdunensis. That suggested to the researchers that S. lugdunensis could combat the growth of the pathogenic bacterium. As such, the antibiotic produced by the bacterium can be developed as a preventive treatment, such as in a nasal spray, to prevent S. aureus from getting into people’s noses in the first place. Around 9% of people carry S. lugdunensis normally.
Lugdunin's chemical structre / Credit: Chemical & Engineering News
“If you want to keep the bacteria in check, you need to understand their lifestyle,” Peschel explains. “And to understand that, we also looked at its competitors.” The investigators checked 90 bacteria obtained from the human nose, but determined that only S. lugdunensis killed MRSA.

The research team also checked how the antibiotic works in other areas by infecting the skin of mice with S. aureus. It was observed that lugdunin ointment not only killed the infection on the surface, but also in deeper layers of the skin.

Lugdunin doesn't only kill MRSA either. It also killed S. aureus that is resistant to the antibiotic glycopeptide as well as vancomycin-resistant Enterococcus spp.

Source: Nature
 
 
 
About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 29, 2018
Videos
SEP 29, 2018
How Researchers Study the Microbes in the Human Gut
Researchers are starting to learn a lot more about the huge number of microbes living in our gastrointestinal tract. But how?...
OCT 08, 2018
Microbiology
OCT 08, 2018
Is a Virus Causing a Mysterious Polio-like Illness in Kids?
Sometime in 2014, the CDC began to get reports of a mysterious illness that was affecting children. More cases have appeared since then....
OCT 11, 2018
Cell & Molecular Biology
OCT 11, 2018
Revealing a 'Double Agent' in the Immune System
Researchers want to enhance our natural defenses to fight a variety of health problems more effectively....
OCT 11, 2018
Microbiology
OCT 11, 2018
New Vaccine Protects Against Lassa Fever and Rabies
In Africa, Lassa fever is a significant threat to public health. It is a member of the same family of viruses as Ebola....
NOV 19, 2018
Microbiology
NOV 19, 2018
The Gut Microbiome Changes Dramatically When Hunter-gatherers Start Farming
Researchers have shown that lifestyle changes have a rapid and significant influence on the human gut microbiome....
DEC 08, 2018
Genetics & Genomics
DEC 08, 2018
The Plague May Have led to the Decline of Neolithic Settlements
An international team of European researchers has discovered a new strain of the bacteria that causes plague....
Loading Comments...